CRISPR Therapeutics AG

NAS:CRSPHealthcareCBOEFTSE:MRUTNASDAQ:NBI

$49.88−0.32%At closeAt close · Wed 21 Oct · ≈ AED 183.18 · Market cap $4.82B · Next earnings Wed 4 Nov · Extended $50.10 +0.44%

Report	EPS estimate	EPS actual	EPS surprise	Revenue estimate (m)	Revenue actual (m)	Revenue surprise
2026-08-03	−1.19	−0.94	+20.6%	7.4	10.2	+36.7%
2026-05-04	−1.19	−1.28	−7.6%	6.1	1.5	−76.0%
2026-02-12	−1.15	−1.37	−19.1%	4.7	0.9	−81.7%
2025-11-10	−1.26	−1.17	+7.1%	9.1	0.9	−90.3%
2025-08-04	−1.47	−1.29	+12.2%	9.4	0.9	−90.5%
2025-05-06	−1.27	−1.58	−24.4%	6.0	0.9	−85.5%
2025-02-11	−1.15	−0.44	+61.7%	8.1	35.0	+334.5%
2024-11-05	−1.33	−1.01	+24.1%	7.7	0.6	−92.2%
2024-08-05	−1.37	−1.49	−8.8%	16.6	0.5	−96.9%
2024-05-08	−1.63	−1.43	+12.3%	3.5	0.5	−85.8%
2024-02-21	−0.07	1.10	+1671.4%	28.1	200.0	+611.5%
2023-11-06	−1.98	−1.41	+28.8%	8.0	—	—